In a study using fibroblasts derived from two patients with early-onset PD with distinct PARK2 mutations, resveratrol treatment activated the AMPK and SIRT1 pathways, resulting in increased mRNA expression of PGC-1α target genes. Here, SIRT1 is linked to Parkinson disease.